IDiyas

For the Inventor, By the Inventor

Cambridge, United Kingdom

David Alan Owen

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 110(Granted Patents)


Location History:

  • Cambridge CB4 4ZG, GB (1993)
  • Cambridge, GB (1997 - 2004)

Company Filing History:

goldMedal24 out of 90 
 
Darwin Discovery Limited
 patents
silverMedal3 out of 26 
 
Chiroscience, Ltd.
 patents
bronzeMedal1 out of 832,718 
Other
 patents

Years Active: 1993-2004

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents
1. 6818622 - Selective MMP inhibitors having reduced side-effects (2004-11-16),
2. 6734189 - Hydroxamic and carboxylic acid derivatives (2004-05-11),
3. 6706719 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity (2004-03-16),
4. 6680338 - Hydroxamic and carboxylic acid derivatives (2004-01-20),
5. 6566384 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity (2003-05-20),
6. 6506764 - Hydroxamic and carboxylic acid derivatives (2003-01-14),
7. 6503910 - Hydroxamic and carboxylic acid derivatives (2003-01-07),
8. 6469020 - Hydroxamic and carboxylic acid derivatives (2002-10-22),
9. 6465468 - Hydroxamic and carboxylic acid derivatives (2002-10-15),
10. 6462042 - Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors (2002-10-08),
11. 6455531 - Hydroxamic acid derivatives (2002-09-24),
12. 6310088 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity (2001-10-30),
13. 6187924 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity (2001-02-13),
14. 6180611 - Peptidyl compounds (2001-01-30),
15. 6118001 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory (2000-09-12),

Sure, I can help you with that.

Title: The Innovation Journey of David Alan Owen: Pioneering MMP Inhibitors and Beyond

Introduction: Meet David Alan Owen, a prolific inventor hailing from Cambridge, GB, with an impressive track record of 27 patents under his belt.

Latest Patents: Among his recent patents is the groundbreaking work on "Selective MMP Inhibitors having Reduced Side-Effects," addressing the critical need for MMP inhibitors with minimal side effects, particularly in alleviating joint pain. Additionally, his research on Hydroxamic and carboxylic acid derivatives has opened new avenues in the field of pharmaceuticals.

Career Highlights: David Alan Owen has made significant contributions during his tenure at companies like Darwin Discovery Limited and Chiroscience, Ltd., where his innovative spirit and scientific acumen have shone brightly. His patent portfolio exemplifies his dedication to pushing the boundaries of scientific discovery.

Collaborations: Alongside his noteworthy solo efforts, David Alan Owen has collaborated with esteemed colleagues such as Andrew Douglas Baxter and John Gary Montana. These collaborations have further enriched his inventive journey and contributed to the collective advancement of scientific knowledge.

Conclusion: In conclusion, David Alan Owen stands as a beacon of innovation in the realm of MMP inhibitors and pharmaceutical derivatives. His relentless pursuit of scientific excellence and commitment to improving patient outcomes underscore the invaluable impact of his inventions in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…